Melanocortin agonist
A melanocortin agonist discussed in sexual-function contexts.
It has an approved indication overseas (a specific female sexual-dysfunction context) with supporting trials. That does not equate to general retail availability or broad use in Australia.
Reported effects include nausea, flushing and blood-pressure changes. Unregulated online "PT-141" carries the usual identity and quality concerns.
Not ARTG-approved as a finished product in Australia at general retail. Where accessed, this is via prescriber-led pathways.
Limited and supervised; any legitimate access is prescriber-led, not over-the-counter.
This entry is general information about PT-141 (Bremelanotide), not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.